MarginsXMarginsX
Home › Markets › Health Care › SUPN

Supernus Inc. (SUPN)

SUPN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$28.83
-2.99% on the day
Market cap
$6.0B
Mid cap
Revenue · 2025
$1.2B
+4.3% on 2024
Net income · 2025
$210.0M
16.9% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1625297/000162828026012237/0001628280-26-012237-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerSUPN on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited Kingdom
IPO yearNot reported by the screener
SEC CIK0001625297
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$1.2B
Net income$210.0M
Operating income$262.0M
Net margin16.9%
Operating margin21.1%
Revenue growth+4.3%
Cash$195.0M
Total assets$1.2B
P/E (computed)28.5×
P/S (computed)4.8×

Warning signs

Cash runway
Cash-flow positive
$305.0M cash at September 30, 2026
Share count, 1 year
-5.5%
2025-10-01 to 2026-10-09 · -13.5% over 3 years
Going-concern doubt
No
10-Q filed October 29, 2026
Insider net buying, 12 months
-$2.6M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-10-29
Cash and burn$305.0M cash; operating cash flow $24.0M a quarter.Report 2026-09-30
Shares outstanding118,035,272 (2026-10-09); 124,853,897 a year earlier; 136,526,357 three years earlier.Cover page 2026-10-09
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Richmond, Virginia, United StatesPCAOB Form AP 2026-03-18
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $229K, sold $2.8M on the open marketSEC Forms 3/4/5 data sets 2026-09-30
Market cap checkThe listing's market cap implies 207,724,098 shares at the 2026-11-13 price; the latest SEC cover count is 118,035,272 as of 2026-10-09. One of the two share counts is stale.Nasdaq screener and SEC cover page

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$356.0M$137.0M$97.0M$305.0M$488.0M$1.4B10-Q 2026-10-29
Q2 2026
2026-06-30
$343.0M$122.0M$229.0M$222.0M$487.0M$1.3B10-Q 2026-08-03
Q1 2026
2026-03-31
$317.0M$89.0M-$9.0M$175.0M$486.0M$1.3B10-Q 2026-04-30
Q4 2025
2025-12-31
$358.0M$102.0M-$221.0M$195.0M$319.0M$1.2B10-K 2026-02-26
Q3 2025
2025-09-30
$314.0M$42.0M-$39.0M$445.0M$322.0M$1.2B10-Q 2026-10-29
Q2 2025
2025-06-30
$302.0M$18.0M$158.0M$510.0M$326.0M$1.2B10-Q 2026-08-03
Q1 2025
2025-03-31
$266.0M$47.0M$75.0M$372.0M$329.0M$1.2B10-Q 2026-04-30
Q4 2024
2024-12-31
$299.0M$21.0M-$17.0M$319.0M$333.0M$1.2B10-K 2026-02-26

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-09-11
Latest annual report10-K2026-02-26
Latest quarterly / interim10-Q2026-10-29
Latest current report8-K2026-11-03
Latest proxyDEFA14A2026-03-27

Source: SEC EDGAR submissions feed, 572 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+13.6%
1 month-16.1%
3 months-22.2%
Year to date-17.2%
1 year-0.4%
From 52-week high-29.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
MIRMMirum Pharmaceuticals Inc.$91.58-2.56%$6.0B
GRFSGrifols S.A.$8.73+0.46%$6.0B
LGNDLigand Pharmaceuticals Incorporated$301.71-2.29%$6.0B
ARWRArrowhead Pharmaceuticals Inc.$44.21-7.47%$6.2B
BLTEBelite Bio Inc$162.56-1.09%$6.5B
MANEVeradermics Incorporated$128.05-1.24%$5.4B
ERASErasca Inc.$15.11-3.51%$5.3B
PTCTPTC Therapeutics Inc.$60.97-3.97%$5.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier